~~<i id='CD1290AD2E'><strike id='CD1290AD2E'><tt id='CD1290AD2E'><pre id='CD1290AD2E'></pre></tt></strike></i>~~

Home» explore» entertainment

entertainment

author：comprehensive 2025-09-29 13:25:49 Page View：76263

Ever since Medicare was given power to negotiate prices for certain medicines, the pharmaceutical industry has argued the move will end badly for patients.

Beyond complaining about price controls and unconstitutional mandates, the key message aimed at the American public has been that innovation will suffer.

This is a familiar but tiring refrain.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Threats against the LGBTQIA+ community intensifying: Department of Homeland Security
Next article： Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

explore

BioMarin wins approval for gene therapy to treat hemophilia A

AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

Readout LOUD: Venture capital, Gilead, and more M&A

AreventurecapitalistsOK?Arebolt-onsgoodforbusiness?Andwhenisitsafetosaysomeoneoverpaid?Wecoveralltha

Dobbs anniversary: the lost opportunity of abortion as health care

NathanHoward/GettyImagesReflectingonthisfirstanniversaryoftheSupremeCourt’sdecisioninDobbstooverturn

The CDC's new social media misinformation war

KIRILLKUDRYAVTSEV/AFP/GettyImagesYou’rereadingthewebeditionofD.C.Diagnosis,STAT’stwice-weeklynewslet